BOUDREAUX GAIL 4
4 · Elevance Health, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
[F1]2026-03-02$294.07/sh−6,713$1,974,092→ 144,307 total - Award
Common Stock
[F2]2026-03-02+16,153→ 160,460 total - Award
Common Stock
[F3]2026-03-02+10,527→ 170,987 total - Tax Payment
Common Stock
[F1]2026-03-03$284.03/sh−1,736$493,076→ 169,251 total - Award
Employee Stock Option (Right to Buy)
[F4]2026-03-02+63,818→ 63,818 totalExercise: $294.07Exp: 2036-03-02→ Common Stock (63,818 underlying)
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.
- [F3]Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
- [F4]The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.
Signature
/s/ Kathleen S. Kiefer, Attorney in fact|2026-03-04